Lombard Odier Asset Management (Switzerland) Sa Biomarin Pharmaceutical Inc Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $4.46 Million - $5.96 Million	-50,802 Reduced 24.64%	155,411 $15.1 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $1.35 Million - $1.82 Million	-16,725 Reduced 7.5%	206,213 $21.3 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $2.27 Million - $2.67 Million	-27,579 Reduced 11.01%	222,938 $18.9 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $2.96 Million - $3.59 Million	-41,353 Reduced 14.17%	250,517 $20.8 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $21.7 Million - $27.1 Million	291,870 New	291,870 $22.5 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account